Imunon, Inc. Long-Term Debt, Maturity, Year Five
Imunon, Inc. (IMNN) had Long-Term Debt, Maturity, Year Five of $754.06 thousand as of 2013-06-30, per its 10-Q filed 2013-08-08.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2013-08-08
- 2013-06-30: Long-Term Debt, Maturity, Year Five $754.06K.
- 2013-03-31: Long-Term Debt, Maturity, Year Five $1.12M.
- 2012-06-30: Long-Term Debt, Maturity, Year Five $568.29K.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2013-06-30 | $754.06K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $1.12M 10-Q · filed 2013-05-09 |
| 2012-06-30 | $568.29K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |